Anna Di Nardo

Prof. Dr. Anna Di Nardo

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2007 in Nature Medicine
Verified
Journal Article
Closed access
KYKenshi Yamasaki
Kenshi Yamasaki
ANAnna Di Nardo
Anna Di Nardo
ABAntonella Bardan
Antonella Bardan
MMMasamoto Murakami
Masamoto Murakami
TOTakaaki Ohtake
Takaaki Ohtake
RGRichard L Gallo
Richard L Gallo

22 November 2009 in Nature Medicine
Verified
Journal Article
Open access
PDF file
YLYuping Lai
Yuping Lai
ANAnna Di Nardo
Anna Di Nardo
TNTeruaki Nakatsuji
Teruaki Nakatsuji
ALAnke Leichtle
Anke Leichtle
YYYan Yang
Yan Yang
RGRichard L Gallo
Richard L Gallo
Gallo and his colleagues report that commensal bacteria on the skin help to dampen inflammation caused by skin injury in mice. They show that, after wounding, necrotic cells release RNA that triggers TLR3 on keratinocytes, causing inflammatory cytokine release. Commensal bacteria in the skin suppress this inflammatory response through triggering TLR2 on the keratinocytes. The normal microflora of the skin includes staphylococcal species that will induce inflammation when present below the dermis but are tolerated on the epidermal surface without initiating inflammation. Here we reveal a previously unknown mechanism by which a product of staphylococci inhibits skin inflammation. This inhibition is mediated by staphylococcal lipoteichoic acid (LTA) and acts selectively on keratinocytes triggered through Toll-like receptor 3(TLR3). We show that TLR3 activation is required for normal inflammation after injury and that keratinocytes require TLR3 to respond to RNA from damaged cells with the release of inflammatory cytokines. Staphylococcal LTA inhibits both inflammatory cytokine release from keratinocytes and inflammation triggered by injury through a TLR2-dependent mechanism. To our knowledge, these findings show for the first time that the skin epithelium requires TLR3 for normal inflammation after wounding and that the microflora can modulate specific cutaneous inflammatory responses.

1 September 2010 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
PDF file
YLYuping Lai
Yuping Lai
ACAnna L. Cogen
Anna L. Cogen
KRKatherine A. Radek
Katherine A. Radek
HPHyun Jeong Park
Hyun Jeong Park
DMDaniel T. MacLeod
Daniel T. MacLeod
RGRichard L. Gallo
Richard L. Gallo
Production of antimicrobial peptides by epithelia is an essential defense against infectious pathogens. In this study we evaluated whether the commensal microorganism Staphylococcus epidermidis may enhance production of antimicrobial peptides by keratinocytes and thus augment skin defense against infection. Exposure of cultured undifferentiated human keratinocytes to a sterile nontoxic small molecule of <10 <!----> kDa from S. epidermidis conditioned culture medium (SECM), but not similar preparations from other bacteria, enhanced human β-defensin 2 (hBD2) and hBD3 mRNA expression and increased the capacity of cell lysates to inhibit the growth of group A Streptococcus (GAS) and S. aureus. Partial gene silencing of hBD3 inhibited this antimicrobial action. This effect was relevant in vivo as administration of SECM to mice decreased susceptibility to infection by GAS. Toll-like receptor 2 (TLR2) was important to this process as a TLR2-neutralizing antibody blocked induction of hBDs 2 and 3, and Tlr2-deficient mice did not show induction of mBD4. Taken together, these findings reveal a potential use for normal commensal bacterium S. epidermidis to activate TLR2 signaling and induce antimicrobial peptide expression, thus enabling the skin to mount an enhanced response to pathogens.

20 January 1998 in Acta Dermato-Venereologica
Verified
Journal Article
Open access
ANAnna Di Nardo
Anna Di Nardo
PWP Wertz
P Wertz
AGA Giannetti
A Giannetti
SSS Seidenari
S Seidenari
Atopic dermatitis skin tends to be easily irritated and appears dry. These clinical peculiarities c...

29 November 2010 in Journal of Experimental Medicine
Verified
Journal Article
Open access
JGJosh Gregorio
Josh Gregorio
SMStephan Meller
Stephan Meller
CCCurdin Conrad
Curdin Conrad
ANAnna Di Nardo
Anna Di Nardo
BHBernhard Homey
Bernhard Homey
MGMichel Gilliet
Michel Gilliet
Plasmacytoid dendritic cells (pDCs) are specialized type I interferon (IFN-α/β)–producing cells that express intracellular toll-like receptor (TLR) 7 and TLR9 and recognize viral nucleic acids in the context of infections. We show that pDCs also have the ability to sense host-derived nucleic acids released in common skin wounds. pDCs were found to rapidly infiltrate both murine and human skin wounds and to transiently produce type I IFNs via TLR7- and TLR9-dependent recognition of nucleic acids. This process was critical for the induction of early inflammatory responses and reepithelization of injured skin. Cathelicidin peptides, which facilitate immune recognition of released nucleic acids by promoting their access to intracellular TLR compartments, were rapidly induced in skin wounds and were sufficient but not necessary to stimulate pDC activation and type I IFN production. These data uncover a new role of pDCs in sensing tissue damage and promoting wound repair at skin surfaces.

1 June 2007 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
KTKristen R. Taylor
Kristen R. Taylor
KYKenshi Yamasaki
Kenshi Yamasaki
KRKatherine A. Radek
Katherine A. Radek
ANAnna Di Nardo
Anna Di Nardo
HGHeidi Goodarzi
Heidi Goodarzi
RGRichard L. Gallo
Richard L. Gallo
Inflammation under sterile conditions is not well understood despite its importance in trauma and autoimmune disease. To investigate this process we established mouse models of sterile injury and explored the role of hyaluronan in mediating inflammation following injury. The response of cultured monocytes to hyaluronan was different than the response to lipopolysaccharide (LPS) despite both being dependent on Toll-like receptor 4 (TLR4). Cultured cells exposed to hyaluronan showed a pattern of gene induction that mimics the response seen in mouse skin after sterile injury with an increase in molecules such as transforming growth factor-β2 and matrix metalloproteinase-13. These factors were not induced by LPS despite the mutual dependence of both hyaluronan and LPS on TLR4. Explanation for the unique response to hyaluronan was provided by observations that a lack of TLR4 or CD44 in mice diminished the response to sterile injury, and together with MD-2, was required for responsiveness to hyaluronan in vitro. Thus, a unique complex of TLR4, MD-2, and CD44 recognizes hyaluronan. Immunoprecipitation experiments confirmed the physical association of TLR4 and CD44. Taken together, our results define a previously unknown mechanism for initiation of sterile inflammation that involves recognition of released hyaluronan fragments as an endogenous signal of tissue injury.